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In This IssueHaploid ESCs Replace Sperm in Mouse IVF
PAGE 605
Yang et al. derive haploid embryonic stem cells and show that they can contribute to various
tissues, including the germline, of fertile mice upon injection into a diploid blastocyst. The
authors also demonstrate that these cells can be genetically engineered and partially retain
imprinting patterns. Most surprisingly, injection of these haploid ES cells into oocytes results
in fertile adults, suggesting potential new approaches for the generation of genetically manip-
ulated organisms.
Genetic Intersection of Neurodevelopment and
Autism
PAGE 525
Talkowski and colleagues identify 22 new loci that contribute to autism and related neurode-
velopmental disorders by combining next-generation sequencing of balanced chromosomal abnormalities with convergent genomic
studies of gene expression, copy number variation, and genome-wide association. Taken together, these data provide support for
a polygenic risk model for autism and give new insights into how different types of mutations of the same genes can lead to variable
disease phenotypes, which may manifest at different stages of life.
Polyadenylation Cut Short in Muscular Dystrophy
PAGE 538
The majority of mammalian genes contain multiple cleavage sites at their 30 UTRs, yet the factors controlling selection of alternative
cleavage and polyadenylation (APA) sites are largely unknown. Jenal et al. show that PABN1 regulates APA by selectively binding and
suppressing proximal cleavage sites. PABN1 is disrupted by triplet repeat expansion in patients with oculopharyngeal muscular
dystrophy, resulting in widespread shortening of mRNAs, which suggests a role for dysregulated APA in the disease.
Streboscopic Spindle Dissection
PAGE 554
Eukaryotic spindles often contain over 100,000 microtubules, creating a dense structure that is difficult to study using conventional
microscopic techniques. Brugues et al. present a new laser ablation method to dissect the organization of microtubules within eu-
karyotic spindles. They find that microtubules are shortest near the poles and that this arrangement arises from spatially regulated
microtubule nucleation, followed by microtubule transport.
Nuclear Import Puts Out the Fire
PAGE 578
Heat shock induces translocation of the molecular chaperone Hsp70 into the nucleus, even as importin b-mediated nucleocytoplas-
mic trafficking is downregulated. Kose et al. now show that Hsp70 translocates into the nucleus via an alternative pathway involving
Hikeshi, a carrier that does not belong to the importin b family. Hikeshi acts via direct binding to both Hsp70 and the nuclear pore
complex, and its activity is essential for cell survival after heat shock.
SUN Up for Laminopathy Insights
PAGE 565
Mutations in the lamin A protein cause muscle dystrophies and premature aging in mice and humans. Chen et al. now provide an
unexpected insight into the underlying mechanism of these laminopathies such as Hutchinson-Gilford progeria. The authors find
that the nuclear envelope protein SUN1 accumulates to abnormally high levels in lamin A
mutant backgrounds. Deletion of SUN1 ameliorates many disease symptoms in mice and
patient cells, indicating that the disease mechanism is not as exclusively tied to dysfunctional
lamin A as previously thought.
Bicoid Needs Help with Boundary Issues
PAGE 618
Morphogen gradients are thought to establish boundaries in developing embryos via mecha-
nisms involving threshold-dependent activation of gene expression. Chen et al. show that the
classic morphogen Bicoid is unable to specify boundary formation in Drosophila embryos in
the absence of three repressor gradients that antagonize Bicoid-mediated activation of
gene expression. These repressors bind Bicoid enhancer elements, and their genetic removal
shifts normally well-separated boundaries to a single position, suggesting that the specifica-
tion of multiple boundaries requires more than a single morphogen.Cell 149, April 27, 2012 ª2012 Elsevier Inc. 499
Bacterial Homewrecker
PAGE 684
Biofilms are drug-resistant multicellular communities of bacteria whose characteristics differ signifi-
cantly from their free-floating counterparts, necessitating distinct strategies to target them therapeu-
tically. Kolodkin-Gal et al. identify norspermidine as a factor that promotes disassembly of biofilms,
formed by a variety of bacteria, by directly interacting with exopolysaccharide, a component of the
extracellular matrix that holds the community of cells together.
Pol II Pausing Helps Stem Cells Stay Grounded
PAGE 590Examination of the transcriptome and epigenome of ground-state pluripotency in embryonic stem cells by Marks et al. reveals a low
prevalence of histone H3K27 trimethylation (a repressive histone mark) and of bivalent domains, which are thought to mark genes
poised for either up- or downregulation. Although these chromatin features establish a permissive context for gene expression, tran-
scription is globally restrained at key developmental genes by promoter-proximal pausing of RNA polymerase II.
Somatic XIC: Not So Random
PAGE 630
X chromosome inactivation is thought to occur randomly in somatic tissue. Jiao et al. now provide evidence for nonrandom imprinting
of the X-linked gene Rnf12 in murine mammary glands. The Rnf12 gene product acts as a survival and morphogenic factor in milk-
producing alveolar cells. Surprisingly, these functions are mediated primarily by the paternal Rnf12 allele as a consequence of
nonrandom X chromosome inactivation in adult mammary epithelial cells.
Finding Druggable Targets in Lung Cancer
PAGE 642
Lung cancer frequently hasmutations in the KRASoncogene, but so far this has proved impossible to target directly. Kumar et al. now
show that lung tumors with mutations in the RAS pathway are dependent on the transcription factor GATA2. Analysis of the GATA2
transcriptional network reveals components that, when targeted in combination, cause striking regression of KRAS-driven lung
tumors in mice.
KRAS Metabolically Reprograms Pancreatic Cancer
PAGE 656
Ying et al. demonstrate that advanced pancreatic cancer relies on continued expression of an activated KRAS mutant. KRAS
signaling alters tumor metabolism by stimulating glucose uptake and channeling glucose intermediates into pathways that drive hex-
osamine and ribose biosynthesis. The work provides mechanistic insights into how oncogenic KRAS promotes metabolic reprog-
ramming and points to potential metabolic targets for therapeutic intervention.
Heart MEDiates Good Metabolism
PAGE 671
Grueter et al. show that the cardiac-specific microRNA miR-208a regulates the levels of MED13, a subunit of the Mediator complex
that controls transcription by thyroid hormone and other nuclear hormone receptors. Surprisingly, disruption of this regulation by
varying the levels of either miR-208 or MED13 in the heart alters whole-body energy homeostasis. These findings point to MED13
and miR-208a as potential therapeutic targets for the treatment of metabolic disorders.
piRNAs for Persistent Memories
PAGE 693
In this issue, Rajasethupathy et al. reveal a mechanism by which piRNAs, small RNAs generally thought to be restricted to the germ-
line, facilitate the formation of memories. They find that piRNAs are expressed in neurons, where, in response to serotonin, they
induce methylation and concomitant silencing of the CREB2 promoter, a repressor of long-term
memory formation. Methylation causes a long-lasting change in CREB2 expression, suggesting
how these molecular events result in the persistence of memory.
Restoring Neuronal Rhythms in Alzheimer’s Model
PAGE 708
Verret et al. reveal howspecificdeficits in inhibitory interneurons can contribute toADpathology. They
show that depletion of Nav1.1, an interneuron-specific voltage-gated sodium channel, is associated
with abnormal patterns of synaptic activity and memory deficits in an hAPP mouse model of AD.
Driving expression of Nav1.1 in inhibitory interneurons not only restores normal gamma activity, but
also rescues the AD-like impairments in memory, oscillatory rhythms, and network synchrony.Cell 149, April 27, 2012 ª2012 Elsevier Inc. 501
